Tag: medicine
-
Opting for CPR but not intubation may not be wise
By Randi Belisomo (Reuters Health) – If you have an advance directive that cherry-picks the interventions you want to receive if your heart suddenly stops, you might want to rethink your choices, according to physicians writing in JAMA Internal Medicine. People who prepare for the possibility of cardiopulmonary resuscitation (CPR) by specifying selected options -…
-
Opting for CPR but not intubation may not be wise
By Randi Belisomo (Reuters Health) – If you have an advance directive that cherry-picks the interventions you want to receive if your heart suddenly stops, you might want to rethink your choices, according to physicians writing in JAMA Internal Medicine. People who prepare for the possibility of cardiopulmonary resuscitation (CPR) by specifying selected options -…
-
Disgraced celebrity surgeon’s spoiled dreams of fame
Dreams of fame and fortune turned into a nightmare for a once-renowned Italian surgeon who compared himself to Doctor Frankenstein and now stands accused of using patients as guinea pigs. Sweden's Karolinska Institute (KI), which awards the Nobel Prize for Medicine, fired Paolo Macchiarini this week after years of controversy. A pioneer in regenerative medicine,…
-
Disgraced celebrity surgeon’s spoiled dreams of fame
Dreams of fame and fortune turned into a nightmare for a once-renowned Italian surgeon who compared himself to Doctor Frankenstein and now stands accused of using patients as guinea pigs. Sweden's Karolinska Institute (KI), which awards the Nobel Prize for Medicine, fired Paolo Macchiarini this week after years of controversy. A pioneer in regenerative medicine,…
-
Nobel Laureate U.S. medical researcher Gilman dies at 74
Dr. Alfred Gilman, a Nobel Laureate medical researcher known for groundbreaking work on cells and diseases, has died at the age of 74 after a long illness, the University of Texas Southwestern Medical School said. Gilman and Martin Rodbell won the 1994 Nobel Prize in Physiology or Medicine for their discovery of the G-protein, the…
-
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
By Ben Hirschler LONDON (Reuters) – AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either…
-
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
By Ben Hirschler LONDON (Reuters) – AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either…
-
High schools listening to scientists, letting teens sleep
SEATTLE (AP) — More school districts around the U.S. are heeding the advice of scientists who have long said that expecting teens to show up to class before 8 a.m. isn't good for their health or their report cards.